What is Imunon Inc?
, a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 3.47M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 12,525 shares $4k | 0 |
| 3-6months | 519,860 shares $34k | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |